The ATPAF2 gene helps cells assemble part of the machinery in mitochondria, the structures that produce usable energy. If this gene does not work properly, cells may not make enough energy, especially in tissues that need a steady supply, such as the brain, muscles, and heart. This gene helps your body support growth and organ function, so pathogenic variants in both copies can cause a rare inherited mitochondrial condition with low muscle tone, developmental delay, feeding problems, or heart involvement.
What is a gene?
Genes are stretches of DNA that hold information cells use to make molecules or regulate processes in the body. Some carry the information needed to make proteins, the working parts of cells. Others mainly help control when certain processes happen, where they happen, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
ATPAF2Gene function
What if the gene works
The ATPAF2 gene helps your cells assemble a protein complex in mitochondria that makes ATP, the cell's main energy source. This supports steady energy production for everyday cell function.
Risk
What if the gene does not work
Changes in the ATPAF2 gene can impair energy production, causing a mitochondrial condition with low muscle tone, developmental delay, and heart problems. Milder and more severe variants can influence when symptoms begin and how strongly they affect the body.
Treatment
What does that mean for your treatment
No ATPAF2-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the ATPAF2 gene.
Conditions associated with ATPAF2
Gene function
What if the gene works
Inside your mitochondria, the ATPAF2 gene helps build a key energy making machine. This supports how the ATPAF2 gene helps mitochondria make energy that cells use every day. When this process runs smoothly, cells can turn food and oxygen into ATP, the main form of usable cellular energy.
The ATPAF2 gene helps put together part of ATP synthase, the protein machine in mitochondria that makes ATP. It guides important pieces into a stable working form so the full machine can be completed.
By helping ATP synthase form correctly, this gene supports steady ATP production, which gives cells usable energy for daily tasks. When it works properly, cells can draw on a more reliable energy supply.
Inside mitochondria, ATPAF2 works with other helper proteins so energy making parts are assembled in the right order. This supports smooth routine activity in many kinds of cells.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ATPAF2 gene can weaken or destabilize a helper protein needed to assemble ATP synthase, the mitochondria’s main energy-making complex. This explains how ATPAF2 gene variants affect mitochondrial energy production: milder changes may leave some assembly activity, while more severe variants can sharply reduce or eliminate it. In people with disease-causing ATPAF2 variants, a larger loss of function is often linked to earlier onset and a more severe mitochondrial condition.
How variants are linked to conditions
Pathogenic variants in the ATPAF2 gene cause a rare inherited mitochondrial condition often called ATP synthase deficiency. Many people with an ATPAF2-related mitochondrial disease develop symptoms in infancy or early childhood, such as poor feeding, low muscle tone, delayed development, or high lactate levels on testing. When disease-causing variants are found in both copies of the ATPAF2 gene, this can confirm the diagnosis. This is the main well-established way ATPAF2 gene variants are linked to conditions.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human, and they are widespread across the population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a clear diagnosis, particularly when more than one gene and environmental influences play a role. In certain situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ATPAF2 gene. People with concerns about their personal or family risk can talk with a doctor or genetic counselor.
Inheritance of ATPAF2 variants
ATPAF2-related conditions are inherited in an autosomal recessive pattern. In practical terms, how ATPAF2 gene variants are inherited usually means a child needs to receive one altered copy from each parent to be affected. When both parents carry an ATPAF2 variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither variant. This pattern affects sons and daughters equally.
What does my ATPAF2 result mean for my family?
For ATPAF2, the main known related condition is inherited in a recessive way, which usually means parents are healthy carriers and brothers or sisters could also be affected or be carriers. Close relatives may want to know that carrier status can run in families, especially if there is a family history of a similar mitochondrial condition. The meaning for relatives depends on the exact genetic result found in your family.
Genetic information
Genetic testing
How you find out about variants
ATPAF2 genetic testing looks for changes in the ATPAF2 gene using a blood sample or saliva. A lab reads the gene’s DNA sequence, often as part of a multi gene panel, exome, or genome test, and compares it with a reference sequence to identify variants and classify what they may mean.
When should I consider getting a genetic test?
Genetic testing for the ATPAF2 gene may be considered when someone has signs of a rare energy-production condition, such as severe early developmental problems, low muscle tone, seizures, or lactic acid buildup. It can also help when a close family member has an ATPAF2 variant or a similar unexplained inherited illness.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the difference comes from how the body absorbs, breaks down, and moves a drug, as well as how strongly the drug acts on its target. These inherited differences are common and are one of several factors, along with age, kidney and liver function, and other medicines, that shape medication response.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that examines how genetic differences affect the way people respond to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. If you want to learn more about this topic, you can find additional information in the LearnHub.
Drugs influenced by the ATPAF2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen, so general medication questions, new symptoms, or treatment concerns are best discussed with your doctor or pharmacist.
History
ATPAF2 entered the genetics literature through research on how cells build the machinery they need to make energy. It was first studied as part of a broader effort to identify human genes that help mitochondria, the cell’s energy centers, work properly. Over time, scientists’ understanding of the gene’s role changed as rare inherited variants in ATPAF2 were linked to mitochondrial disease in some families. That connection helped place ATPAF2 within a growing group of genes important in energy related conditions. Its history is mainly one of steady laboratory and clinical discovery rather than a widely publicized medical story.